Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
No verified gene, transcript, or long noncoding RNA named **VWA5B1 antisense RNA 1 (VWA5B1-AS1)** can be found in major genomic, chemical, or molecular target databases as of 2024. There is a protein-coding gene called **von Willebrand factor A domain containing 5B1 (VWA5B1)**[2][8], but there is no documented or characterized antisense RNA with the suffix "-AS1" associated with this locus. By contrast, several well-characterized antisense lncRNAs such as BBOX1-AS1 and OBI1-AS1 exist for other loci, many of which are known to play oncogenic or regulatory roles[1][5]. However, the name "VWA5B1-AS1" does not appear as a recognized entity in scientific literature or databases and may be a misnomer, misspelling, or an uncharacterized/unannotated transcript. **Key context:** - VWA5B1: Encodes a protein (von Willebrand factor A domain containing 5B1); found in human and various mammals[2][8]. - Antisense RNAs (AS1): Many genes have an antisense RNA, typically indicated with the "-AS1" suffix, often lncRNAs with regulatory function[3][7]. However, not all genes have documented antisense transcripts, and uncharacterized or predicted transcripts may not have functional annotation or disease association. - There is robust data on BBOX1-AS1 (for BBOX1), but not for VWA5B1-AS1[1]. **Summary:** "VWA5B1 antisense RNA 1" (VWA5B1-AS1) is not a verified or recognized therapeutic target. There is no evidence for its existence or characterization; thus, all related data (such as molecular class, function, drugs, safety, etc.) must be considered null or missing. This entry appears to be incorrect or incomplete, likely due to a nomenclature or curation error.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VWA5B1 antisense RNA 1 (VWA5B1-AS1).